Randomized controlled Phase III trial to evaluate omentum preserving gastrectomy for patients with advanced gastric cancer (JCOG1711, ROAD-GC).

Jpn J Clin Oncol 2020 Jul 8. Epub 2020 Jul 8.

Department of Gastric Surgery, Shizuoka Cancer Center, Shizuoka, Japan.

Gastrectomy with omentectomy and D2 lymph node dissection is the current standard procedure for locally advanced gastric cancer. However, some retrospective studies have reported that omentectomy increased post-operative abdominal complications but provided no survival advantage over omentum preservation. Therefore, we plan a randomized controlled phase III trial to confirm the non-inferiority of omentum preservation compared with omentectomy in patients with cT3 (SS) or cT4a (SE) gastric cancer. A total of 1050 patients will be enrolled from 62 institutions over a period of 6.5 years. The primary end point is relapse-free survival, and the secondary end points are overall survival, blood loss, operation time and adverse events. This trial has been registered at the UMIN Clinical Trials Registry as UMIN000036253.

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyaa113DOI Listing
July 2020

Publication Analysis

Top Keywords

gastric cancer
12
iii trial
8
advanced gastric
8
phase iii
8
omentum preservation
8
controlled phase
8
randomized controlled
8
ct3 ct4a
4
patients ct3
4
omentectomy patients
4
compared omentectomy
4
ct4a gastric
4
cancer total
4
will enrolled
4
patients will
4
1050 patients
4
total 1050
4
preservation compared
4
non-inferiority omentum
4
complications provided
4

Similar Publications